FOXP3 and colitis: Onji and colleagues have reported that carbonic anhydrase I-pulsed bone marrow-derived DC generated in vitro with GM-CSF/IL-10/TGF-β inhibited colitis progression via rebalancing the Foxp3+/TH17 T-cell ratio inside the MLN (59).